As an invention funded by a grant provided by the U.S. Defense Advanced Research Projects Agency (DARPA), ionized Hydrogen Peroxide (iHP) was developed as a direct response to weaponized anthrax attacks.

After the attacks, iHP began to establish itself in a more mainstream capacity with registration as a Hospital-Healthcare, general, and multiple-use disinfectant with exceptional efficacy against bacteria, bacterial spores, viruses, mold spores, and many other pathogens.

With iHP achievable solely through Binary Ionization Technology (BIT), the technology became the first combination of both solution and technology to be registered by the EPA as a Hospital-Healthcare and general-use disinfectant.

Binary Ionization Technology utilizes a solution comprised of 7.8% hydrogen peroxide as a sole active ingredient, naturally enhanced by a cold plasma arc. As a result, SteraMist application features superior material compatibility with a quick-acting disinfection and decontamination.